Clinical SciencePopulation insulin sensitivity from sparsely sampled oral glucose tolerance tests
Introduction
Estimates of insulin sensitivity have been useful to characterize different populations at high risk for diabetes. Several methods exist to estimate insulin sensitivity. The gold standard for measurement of insulin sensitivity is the euglycemic-hyperinsulinemic clamp [1]. The minimal model [2] calculated from the frequently sampled intravenous glucose tolerance test (FSGTT) is another methodology that yields estimates of insulin sensitivity with a good correlation to the euglycemic-hyperinsulinemic clamp [3]. However, both the clamp and FSGTT are time-consuming, require multiple samples, and require steady-state for the clamp. Furthermore, the clamp and the FSGTT methods do not estimate insulin sensitivity in the physiologic state. They both measure insulin sensitivity in response to an intravenous rather than an oral stimulus of glucose.
Surrogate measures of insulin resistance, such as the HOMA-IR [4] and quantitative insulin sensitivity check index (QUICKI [5]) are easier to perform but based on fasting levels of glucose and insulin. HOMA-IR and QUICKI show reasonable correlation with euglycemic-hyperinsulinemic clamp in normal subjects, but each has failed to predict insulin sensitivity in subjects with impaired beta-cell function [6]. Thus, the use of these surrogate measures of insulin sensitivity remains controversial.
The oral glucose tolerance test (OGTT) remains the gold standard to diagnose diabetes and prediabetes. Since this is a more physiologic glucose stimulus, surrogate measures of insulin sensitivity using the OGTT have been developed. Underlying genotype-phenotype abnormalities can have different impact on fasting and postprandial glucose levels. The Matsuda index, a composite surrogate measure using 5 points from the OGTT, was developed to account for the heterogeneity of the diabetes phenotypes and have a broader measure of insulin sensitivity [7]. Another measure of insulin sensitivity from the OGTT is the oral minimal model by Dall Man et al [8]. The original model was developed using 20 samples over 300 minutes. A subsequent study showed that a 2-hour 7-sample OGTT correlates well with the 300 minutes 11-sample OGTT measurement of insulin sensitivity [9]. The oral minimal model is widely used. However, in most studies, especially those with large populations, a collection of 5- or 7-samples over 2 hours can be demanding on the research subject and may not be feasible in studies of large populations.
Our investigation aimed to develop a sparse sample method of measuring insulin sensitivity that will enable the use of the Dalla Man’s model in studies where less than 7 samples have been collected. When insufficient samples have been obtained per subject, a common practice in pharmacokinetic/pharmacodynamic (PK/PD) analysis has been to combine the data to yield a population model [10]. Population modeling extends the kinetic mathematical model to include fixed and random effects and, as such, are often known as mixed-effects models and can be nonlinear when the fixed part is not linear and referred as nonlinear mixed effects, NLME, models [11]. NLME models have previously been used to obtain estimates of minimal model parameters using FSGTT simulated sparse sampling data by using 13 samples from the FSGTT [12,13] and with 10 samples for estimation of Si from OGTT data [12]. These multiple samples are not feasible for large populations. Therefore, a quantitative estimate of insulin sensitivity that uses fewer time points during an OGTT and characterizes insulin sensitivity on a cohort level will be useful for studies assessing large numbers of people at high risk for type 2 diabetes.
Section snippets
Sparse sampling population non-linear multilevel modeling (NLML)
To obtain population estimates of all indices, we used NLML. In similar fashion to linear multilevel models for repeated measures, nonlinear models can be viewed as hierarchical models with fixed-effects level and random effects explaining a subject’s between and within variability. The “level” here refers to the individual sources of variance within the hierarchical organization of the data. For example, here we will specify a simple linear regression model in hierarchical or multilevel format
Simulated subjects
As outlined in the methods, we have generated simulated 50 virtual subjects that had varying levels of insulin sensitivity for the purpose of validating our novel NLML modeling methodology. Using 10 simulated samples of glucose and insulin per subject, we were able to obtain unique estimates of SI for each of the 50 “virtual” subjects with an average coefficient of variation (CV=16±3%). The mean insulin sensitivity for all 50 subjects was 3.73 (95% CI: 3.36 – 4.10) 10-4.μU/ml.min-1.
Discussion
In this article, we show that using our NLML population modeling approach on sparsely sampled OGTT data with only 3 samples per subject; we were able to detect changes in insulin sensitivity equivalent to previously quantified with the classical two-stage population modeling approach. Our methodology utilizes the Dalla Man’s OGTT model [8] and NLML population model to provide population estimates of SI. In contrast to previous approaches, our methodology does not provide individual estimates of
Acknowledgments
This work was funded by K08DK0830361 (D.D.S) and was supported by the National Center for Advancing Translational Sciences Award number (UL1TR002378) from the National Institutes of Health and National Research Resources.
References (26)
- et al.
Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients
Eur J Pharm Sci.
(2017 Nov 15) - et al.
Application of the SAAM modeling program to minimal model analysis of intravenous glucose tolerance test data
Comput Methods Programs Biomed.
(1990 Dec) - et al.
Glucose clamp technique: a method for quantifying insulin secretion and resistance
Am J Physiol.
(1979 Sep) - et al.
Quantitative estimation of insulin sensitivity
Am J Physiol.
(1979 Jun) - et al.
The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values
Diabetes
(1986 Mar) - et al.
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
Diabetologia
(1985 Jul) - et al.
Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans
J Clin Endocrinol Metab.
(2000 Jul) - et al.
Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus
J Clin Endocrinol Metab.
(2002 Nov) - et al.
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
Diabetes Care.
(1999 Sep) - et al.
The oral glucose minimal model: estimation of insulin sensitivity from a meal test
IEEE Trans Biomed Eng.
(2002 May)
Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals
Diabetes.
Mathematical modeling and simulation in animal health. Part III: using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics
J Vet Pharmacol Ther.
Nonlinear mixed effects to improve glucose minimal model parameter estimation: a simulation study in intensive and sparse sampling
IEEE Trans Biomed Eng.
Cited by (2)
Fingertip capillary dynamic near infrared spectrum (DNIRS) measurement combined with multivariate linear modification algorithm for noninvasive blood glucose monitoring
2021, Vibrational SpectroscopyCitation Excerpt :When the fluctuation range of blood glucose exceeds this range, it is diagnosed as diabetes or suspected diabetes [6]. It is considered that the most accurate way to diagnose diabetes is to monitor the fluctuation of blood glucose concentration for a certain period of time after a meal [7,8]. The Fasting Glucose Test (FGT) or the Oral Glucose Tolerance Test (OGTT) are the gold standard for the diagnosis of diabetes [9,10].
- 1
Contributed equal work.